Matthew Feinsod

Interim Chief Medical Officer, Applied Genetic Technologies Corporation.

Companies

Kalaris Therapeutics, Inc.Chief Medical Officer Mar 18, 2025 to now¹
Applied Genetic Technologies CorporationInterim Chief Medical Officer Sep 15, 2017 to Jul 31, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kalaris Therapeutics, Inc. KLRS4,030 shares³$8.8K at $2.19Mar 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 18, 2025Granted 4,030 shares of Kalaris Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKalaris Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARApplied Genetic Technologies Corporation, Interim Chief Medical Officer
3
SEC EDGARKalaris Therapeutics, Inc. shares after the filing of Mar 18, 2025